Načítá se...
Should metformin remain the first-line therapy for treatment of type 2 diabetes?
Metformin is a biguanide that is used as first-line treatment of type 2 diabetes mellitus and is effective as monotherapy and in combination with other glucose-lowering medications. It is generally well-tolerated with minimal side effects and is affordable. Although the safety and efficacy of metfor...
Uloženo v:
| Vydáno v: | Ther Adv Endocrinol Metab |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7809522/ https://ncbi.nlm.nih.gov/pubmed/33489086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042018820980225 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|